https://assets.capyfin.com/instruments/678fdc13234e27009c5d61d3.png avatar
NewAmsterdam Pharma
🇳🇱 NASDAQ:NAMS

NewAmsterdam Pharma Q1 2025 Earnings Report

Total Revenue
$2.95M
Previous year: $1.4M
+110.6%
EPS
-$0.41
Previous year: -$1.06
-61.3%

NewAmsterdam Pharma Revenue

NewAmsterdam Pharma EPS